Clinical Trials on Respiration in South Africa

Total 210 results

Reig Jofre Group

Completed

Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg

Allergy

South Africa
Medtronic BRC

Completed

Respiration Patterns With Impedance in LINQ (EPIQ)

Breathing Exercises

South Africa
University of Cape Town
Red Cross War Memorial Children's Hospital

Unknown

Endotracheal Dilator to Improve Oxygenation (EDITION2)

Pediatric Respiratory Diseases | Tracheal Stenosis | Airway Disease

South Africa
Attikon Hospital

Completed

Correlation of the Hand Grip Force With Maximum Inspiratory and Maximum Expiratory Pressure, in Critical Ill Patients

Intensive Care Unit Syndrome

Greece
Pharmaxis

Completed

Inspiratory Flow and Volumes in Bronchiectatics

Bronchiectasis

Australia
Sheffield Children's NHS Foundation Trust
University of Sheffield

Completed

Physiotherapy for Children With Dysfunctional Breathing (PhysDB)

Dysfunctional Breathing

United Kingdom
Medical University of South Carolina

Recruiting

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Gastric Content Aspiration

United States
TFF Pharmaceuticals, Inc.

Recruiting

An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

Lung Transplant Rejection

Australia
Medical University of South Carolina

Terminated

Feasibility of Music Therapy for Spontaneous Breathing Trials

Intubation | Mechanical Ventilation | Music Therapy | Spontaneous Breathing Trial

United States
Biosplice Therapeutics, Inc.

Withdrawn

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Medical University of South Carolina

Completed

Effects of GLP-1 Agonists on Gastric Volume

Diabetes | Glucagon-like Peptide 1 | GLP-1 | Gastric Content Aspiration

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Feasibility of Inspiratory Muscle Training in People With COPD Who Decline Pulmonary Rehabilitation

Pulmonary Disease, Chronic Obstructive

United Kingdom
Aerami Therapeutics

Completed

Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

Pulmonary Arterial Hypertension

Australia
Novartis Pharmaceuticals

Completed

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo (EDIT)

Cystic Fibrosis

Russian Federation, Egypt, Romania, Estonia, Latvia, Lithuania, Bulgaria, South Africa, India
Alkermes, Inc.

Completed

ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Institute of Progressive Medicine

Active, not recruiting

Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Covid19

United States
GlaxoSmithKline

Completed

To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.

Sleep Disordered Breathing | Congestion, Nasal

Australia
Medical University of South Carolina
National Institutes of Health (NIH)

Completed

Yogic Breathing Changes Salivary Components

Cancer | Neurodegenerative Diseases | Alzheimer Disease

United States
GlaxoSmithKline

Completed

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Ukraine, Spain, South Africa, Italy
Mylan Inc.
Theravance Biopharma

Completed

Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD

Chronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)

United States
ResMed

Completed

Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration

Cheyne-Stokes Respiration | Heart Failure, Congestive

Australia
InMode MD Ltd.

Completed

Evaluate the Effect of Abdominal Electrical Muscle Stimulation on Abdominal Wall Restoration in Post - Partum Women

Diastasis Recti | Abdominal Wall Restoration

United States
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
Evangelismos Hospital
University of Thessaly

Recruiting

CPAP Versus HFNO for the Treatment of Acute Hypoxemic Respiratory Failure Due to Community Acquired Pneumonia

Pneumonia | Respiratory Failure

Greece
Kuopio University Hospital
John Hunter Hospital

Recruiting

Reference Ranges for the Cough Responsiveness to Inhaled Mannitol

Cough

Australia, Finland
Sunovion

Terminated

A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

Asthma

United States
Medical University of South Carolina

Completed

Efficacy of SLN Block for Chronic Cough

Cough | Superior Laryngeal Nerve Block | Neurogenic Cough

United States
National Health and Medical Research Council, Australia
Doris Duke Charitable Foundation; Cancer Council Tasmania; Duke Institute on... and other collaborators

Completed

Palliative Oxygen for the Relief of Breathlessness

Dyspnea

Australia, United Kingdom, United States
Aqualung Therapeutics Corp.

Completed

First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100

ARDS, Human

Australia
Boehringer Ingelheim

Completed

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Lithuania, Slovakia, United Kingdom
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Respiratory Disorders

Australia
Insmed Incorporated
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Mycobacterium Infections, Nontuberculous

United States, Canada
VA Office of Research and Development
William Jennings Bryan Dorn VA Medical Center

Recruiting

Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure

Heart Failure | Dyspnea; Cardiac

United States
GlaxoSmithKline

Completed

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Germany, Poland, Romania, United States, Czechia, Russian Federation
ResMed

Unknown

An Exploratory Investigation of the Use of Drive App to Measure Sleep Parameters in Users of CPAP Therapy

Obstructive Sleep Apnea

Australia
ResMed

Completed

Modified AutoSet Device vs Existing AutoSet Device, the Assessment of Efficacy and Subjective Comfort of the Treatment.

Sleep Apnea

Australia
ResMed

Recruiting

Post Market Clinical Follow up of ResMed Mask Systems

Obstructive Sleep Apnea

Australia
ResMed

Completed

Usability Evaluation of Menai CPAP Masks

Obstructive Sleep Apnea

Australia
Vapotherm, Inc.
University of Texas; University of Tennessee; Memorial Hermann Texas Medical... and other collaborators

Completed

High Flow Therapy for the Treatment of Respiratory Failure in the ED

Acute Respiratory Failure

United States
Flinders University

Completed

Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea (QOSA)

Sleep Apnea, Obstructive

Australia
GlaxoSmithKline

Completed

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease

Pulmonary Disease, Chronic Obstructive

United States, Canada, Germany, Romania, Poland, Czechia
Flinders University
Bayer

Completed

BAY2586116 Nasal Spray and OSA Severity

Sleep Apnea, Obstructive

Australia
ResMed

Completed

Performance of the Salt Lake Mask System

Obstructive Sleep Apnea

Australia
Fisher and Paykel Healthcare

Completed

SensAwake™ Sleep Quality Trial (SASQT)

Sleep Apnea, Obstructive

Australia
ResMed

Completed

Nexus Compliance Study

Obstructive Sleep Apnea

Australia
GlaxoSmithKline

Completed

A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Romania, Russian Federation, United States, Ukraine
StimAire Australia Pty Ltd

Terminated

StimAire Sleep Study

Obstructive Sleep Apnea

Australia
ResMed

Completed

Performance of the Tasman Continuous Positive Airway Pressure (CPAP) System

Obstructive Sleep Apnea

Australia
Sheffield Children's NHS Foundation Trust

Completed

Paediatric Oximetry Algorithms - Normative Data Collection

Sleep Apnea Syndromes in Children

United Kingdom
ResMed

Completed

Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo

Sleep Apnea, Obstructive

Australia

Clinical Trials on Respiration in South Africa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations